A detailed history of Nan Fung Group Holdings LTD transactions in Argenx Se stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 430 shares of ARGX stock, worth $268,242. This represents 0.23% of its overall portfolio holdings.

Number of Shares
430
Holding current value
$268,242
% of portfolio
0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$434.22 - $551.9 $186,714 - $237,317
430 New
430 $233,000
Q1 2023

May 12, 2023

BUY
$334.23 - $403.65 $106,953 - $129,168
320 Added 28.83%
1,430 $532,000
Q1 2022

May 13, 2022

SELL
$254.45 - $351.06 $5,089 - $7,021
-20 Reduced 1.77%
1,110 $350,000
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $307,371 - $398,923
1,130 New
1,130 $396,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.